Theravance Biopharma Ireland and Janssen Biotech entered into a co-development and commercialization agreement over TD-1473, an inflammatory intestinal disease inhibitor.
Motus GI will sell 4.25 million shares of its common stock at $6 per share as it attempts to raise $25.5 million through a U.S.-based initial public offering
The FDA and Pentax announced a voluntary recall of all ED-3490TK video duodenoscopes to replace a series of parts and update the operations manual.
Ferring Pharmaceuticals’ low-volume bowel preparation Clenpiq is now available in the U.S. via prescription.
More articles on gastroenterology:
UroLife designates Midtown Urology Associates a UroLife Center of Excellence: 3 insights
The definition of ‘outpatient’ ACDF and lumbar discectomy procedures can be misleading: 5 insights
Senate report: 5 opioid manufacturers paid $9M to 14 patient advocacy groups — 8 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
